netFormulary NHS
North Central London
Joint Formulary
 Search
 Results

Looking for empagliflozin found 8 matches

Open monograph to display formulary status BNF Category
  Restricted Drug empagliflozin
(Type 2 diabetes)
Endocrine system - SGL2 inhibitors - 06.01.02.03
  Restricted Drug empagliflozin
(Metabolic syndromes)
Short term approval only - Approved under evaluation - 21.01
 
Non Formulary BNF Category
  empagliflozin + linagliptin  (Glyxambi) Endocrine system - Other antidiabetic drugs - 06.01.02.03
  empagliflozin + Metformin  (Synjardy) Endocrine system - Other antidiabetic drugs - 06.01.02.03


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA336: Empagliflozin for type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
link in drug section NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)


 

netFormulary